Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ngm Biopharmaceuticals Inc (NQ: NGM )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.550 (545)
Ask (Size) 1.610 (1)
Prev. Close 1.540
Today's Range N/A - N/A
52wk Range 0.6400 - 2.200
Shares Outstanding 78,049,340
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NGM Bio Announces Closing of Tender Offer
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire

Performance

More News

Read More
NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM
From Kahn Swick & Foti, LLC
Via Business Wire
Looking Into NGM Biopharmaceuticals's Recent Short Interest
Via Benzinga
Why NGM Biopharmaceuticals Stock Is Blasting Higher
Via Benzinga
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM
From Kahn Swick & Foti, LLC
Via Business Wire
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is Cancer-Focused NGM Biopharmaceuticals Stock Trading Lower On Monday?
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
NGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NGM Biopharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), NGM Biopharmaceuticals, Inc. (Nasdaq – NGM), VIZIO Holding Corp. (NYSE - VZIO), HireRight Holdings Corporation (NYSE – HRT)
From Brodsky & Smith LLC
Via GlobeNewswire
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
NGM Bio to Participate in the Cowen 44th Annual Health Care Conference
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
B. Riley Securities Maintains Buy Rating for NGM Biopharmaceuticals: Here's What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
NGM Bio Presents Positive Phase 2b Results from the ALPINE 4 Trial of Aldafermin in Patients with Compensated Cirrhosis (F4) Due to NASH at AASLD The Liver Meeting®
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
NGM Bio to Participate in Upcoming Investor Conferences
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.